Word: roussell
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
...middle, until recently, was the drug's producer, France's Roussel Uclaf. Its corporate parent, Germany's huge Hoechst chemical company, feared a pro-life boycott of its American products if it allowed RU 486 to be marketed in the U.S. And Yorkin threatened a pro-choice boycott if it didn't. In the face of this dilemma and some badgering by the FDA, the company did what a typically cautious multinational would: it passed its burden (or tried to, anyway) onto the shoulders of someone else, in this case the nonprofit Population Council...
Those political barriers, however, are quickly crumbling. Two days after his Inauguration, President Clinton ordered his Administration to "promote the testing, licensing and manufacturing" of RU 486. Until then, the French manufacturer of the drug, Roussel Uclaf, and its German parent company, Hoechst AG, had steadfastly shied away from becoming involved in the American market for fear of infuriating antiabortion activists. But in April, at the instigation of the U.S. Food and Drug Administration, Roussel announced a compromise: it agreed to license RU 486 to the U.S. Population Council, a nonprofit organization based in New York City, which in turn...
...When they invent new ways to kill children, we will invent new ways to save them," warns the Rev. Keith Tucci of Operation Rescue National. A coalition of antiabortion forces has scheduled a demonstration in front of the French embassy in Washington on June 18, just three days before Roussel Uclaf holds its annual meeting in Paris...
...Under President Clinton, who supports abortion rights, the Food and Drug Administration first dropped its opposition to the French-developed pill. Now comes another step. After years of refusing even to seek American permission to market its product out of fear of becoming enmeshed in the abortion controversy, manufacturer Roussel Uclaf has agreed to license the pill to the Population Council, based in New York City...
With Bill Clinton in charge, Roussel Uclaf may be reconsidering. Its president, Edouard Sakiz, met with FDA Commissioner David Kessler and agreed in principle that the U.S. should have RU 486. Sakiz prefers that another firm handle distribution. If he finds one, a large clinical trial could soon begin...